Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study
Author:
Funder
Regione Lazio Italy
Ministero della Salute
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases
Link
http://link.springer.com/content/pdf/10.1186/s12879-018-3125-6.pdf
Reference46 articles.
1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-a, non-B viral hepatitis genome. Science. 1989;244(4902):359–62. PubMed PMID: 2523562.
2. Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: global epidemiology and strategies for control. Clin Microbiol Infect. 2016;22(10):833–8. https://doi.org/10.1016/j.cmi.2016.07.035 . Epub 2016 Aug 11. Review. PubMed PMID: 27521803.
3. Koretz RL, Lin KW, Ioannidis JP, Lenzer J. Is widespread screening for hepatitis C justified? BMJ. 2015;350:g7809. https://doi.org/10.1136/bmj.g7809 . PubMed PMID: 25587052.
4. Ahmad J, Hepatitis C. BMJ. 2017;358:j2861. https://doi.org/10.1136/bmj.j2861 . PubMed PMID: 28684552.
5. WHO. Hepatitis C Fact sheet N°164. http://www.who.int/en/news-room/fact-sheets/detail/hepatitis-c . Accessed 05 May 2018.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hepatitis C Virus Nonstructural Protein 3 Increases Secretion of Interleukin-1beta in HEK293T Cells with a Reconstructed NLRP3 Inflammasome;Molecular Biology;2023-10
2. Hepatitis C Virus Nonstructural Protein 3 Increases Secretion of Interleukin-1beta in HEK293T Cells with Reconstructed NLRP3 Inflammasome;Молекулярная биология;2023-09-01
3. Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis;Heliyon;2023-05
4. Hepatitis C virus: A critical approach to who really needs treatment;World Journal of Hepatology;2022-01-27
5. Favorable impact in hepatitis C–related mortality following free access to direct‐acting antivirals in Spain;Hepatology;2021-12-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3